ICD 10 CM E09.49 | Description & Clinical Information

ICD 10 E09.49 describes a specific type of diabetes mellitus (DM) that is induced by drugs or chemicals and is accompanied by neurological complications, including other diabetic neurological complications, which is a secondary form of diabetes resulting from prolonged use of antidepressants, antipsychotics, thiazide diuretics, or steroids, and is documented by the healthcare provider when there is no other code that represents the neurological complications associated with DM.

Official Description Of E09.49

The ICD 10 CM book defines ICD 10 code E09.49 as:

Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication
Parent Code Notes: E09

Excludes1: diabetes mellitus due to underlying condition (E08.-)
gestational diabetes (O24.4-)
neonatal diabetes mellitus (P70.2)
postpancreatectomy diabetes mellitus (E13.-)
postprocedural diabetes mellitus (E13.-)
secondary diabetes mellitus NEC (E13.-)
type 1 diabetes mellitus (E10.-)
type 2 diabetes mellitus (E11.-)

Code first poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4 or 6)

Use additional code to identify control using:
insulin (Z79.4)
oral antidiabetic drugs (Z79.84)
oral hypoglycemic drugs (Z79.84)

Clinical Information

The diagnosis describes by the ICD 10 CM E09.49 code stems from the use of certain medications that increase blood sugar levels. These medications, if not discontinued, can eventually lead to permanent diabetes mellitus. The condition can manifest in various forms, particularly as drug or chemical-induced DM with neurological complications as well as other diabetic neurological complications.

Individuals with this diagnosis may experience a range of symptoms, depending on which nerve is affected. These can vary greatly in severity, ranging from mild to entirely disabling. Common symptoms related to nerve issues include numbness, double vision, dizziness, and loss of sensation, which can lead to unnoticed injury and infection. Bladder and sexual dysfunction are also common neurological symptoms. General symptoms include increased thirst and urinary frequency, extreme hunger, fatigue, weight loss, and frequent infections. Other symptoms may present depending on the underlying cause of the condition, such as weakness, pain, difficulty breathing, loss of appetite, anemia, high blood pressure, and night sweats.

Medical providers diagnose this condition based on both the patient’s medical history and a diagnostic neurological examination, as well as the appearance of signs and symptoms. To confirm a diagnosis, providers may also order various laboratory tests. These might include blood tests for fasting plasma glucose, levels of HbA1c, and lipid profiles, as well as urine and stool examinations. Additional tests such as nerve conduction study (NCS), electromyography (EMG), and nerve biopsy may be utilized to precisely detect and identify any nerve disorders.

It’s important to note that there is no known cure for permanent nerve damage associated with this condition. Instead, treatment for nerve damage is generally symptomatic, with pain management techniques utilized in conjunction with antidepressants and anticonvulsants. In contrast, depending on the type of diabetes and the patient’s blood glucose levels, DM is treated with either insulin or noninsulin therapies.

In conclusion, the ICD 10 CM E09.49 diagnosis code pertains to medication-related increases in blood sugar levels that can lead to permanent diabetes mellitus, as well as a range of potential neurological complications. Patients with this diagnosis can exhibit a variety of symptoms, and medical providers typically diagnose the condition based on a combination of medical history inquiries, diagnostic neurological examinations, and laboratory testing. Effective treatment generally focuses on symptomatic pain management approaches in tandem with antidepressants and anticonvulsants, and blood glucose levels are often treated with a combination of insulin and noninsulin therapies.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *